Jakub Gubański
Biography
Overview
Jakub Gubański focuses his practice on competition law matters and mergers & acquisitions.
Since the beginning of his legal career at White & Case, Jakub has provided legal advice on the antimonopoly aspects of cross-border concentrations of business entities, in particular on the energy, insurance, healthcare, telecommunication, media, IT and real estate markets. He has advised numerous companies on the merger control rules in Poland and provided guidance in relation to compliance with antitrust and competition law in the EU and Poland. He has also represented clients in the proceedings before competition authorities.
Experience
Polenergia S.A.: representation of Polenergia S.A. on the signing of an investment agreement to establish a special purpose vehicle, jointly controlled by Green Genius (part of the Modus Group), which will act as Polenergia's local partner in the Lithuanian market. The agreement will establish a joint venture to develop wind power projects in the Baltic Sea in Lithuania's territorial waters or in the country's exclusive economic zone. The first offshore wind power project in Lithuania in the Baltic Sea is expected to start operations in 2030 and will have a capacity of approximately 700 MW.
Aquiline Capital Partners Limited: representation of Aquiline Capital Partners Limited, a private investment firm based in New York and London specializing in investments in financial services and technology, in connection with the acquisition of the Virtus Lab Group, a software development company.
Nets Holding A/S: representation of Nets Holding A/S, one of the largest payments companies in Europe, on its acquisition of shares and assets comprising the payments business of paytec GmbH, a German payments company.
Polenergia S.A.: representation of Polenergia S.A., the largest private energy group in Poland, on the signing of a final agreement for the acquisition of a 100% stake in Edison Energia S.A., one of the fastest growing photovoltaic systems installation companies in Poland.
MidEuropa: representation of MidEuropa in connection with its acquisition of Sage sp. z o.o., which provides accounting software services to small and medium enterprises in Poland, from the Sage Group Plc.
Nets Denmark A/S: in October 2020, White & Case obtained the first positive decision in Poland on the control of foreign investment (FDI) issued by the President of the Competition and Consumer Protection Office. The application was also the first application of this kind submitted in Poland. The application was submitted on behalf of the Nets Group, a European leader on the market of payment services, and its owner, the private equity fund Hellman & Friedman, in order to finalize the transaction involving the Nets Group's acquisition of Centrum Rozliczeń Elektronicznych Polskie ePłatności S.A. (PeP).
Global Compute Infrastructure LP: representation of Global Compute Infrastructure LP in connection with the acquisition of ATM S.A., one of the largest data center operators and communications infrastructure businesses in Poland and CEE, from a consortium of funds managed by MCI Capital and Mezzanine Management.
Play Communications S.A.: representation of Play Communications S.A., the leading mobile network operator in Poland, and its reference shareholders Novator and Olympia, in connection with the ILIAD SA's €2.2 billion all cash public tender offer for all of the shares in Play.
Brookfield Infrastructure Partners L.P.: representation of a consortium composed of Brookfield Infrastructure, the leading global infrastructure company, and its institutional partners and GIC in connection with the Polish law aspects of the USD 8.4 billion acquisition of Genesee & Wyoming Inc.
MidEuropa: representation of MidEuropa, a leading private equity investor in Central and Eastern Europe, in connection with the Polish law aspects of the sale of Walmark a.s., a leading consumer healthcare company in Central and Eastern Europe with a unique portfolio of iconic brands and direct presence in nine EU countries, to STADA Arzneimittel AG.
